MONDAY, Aug. 19, 2019 (HealthDay News) -- The Barostim Neo System was granted U.S. Food and Drug Administration approval to treat symptoms of patients with advanced heart failure who are not candidates for treatment with other devices such as ...
from Google Alert - health https://ift.tt/2z7M3bi
via IFTTT
0 comments:
Post a Comment